Stockreport

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF Cortigent is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind The Company is also developing a new medi [Read more]